Spear Bio
Woburn, Massachusetts, United States
Spear Bio is developing an ultrasensitive immunodiagnostics and proteomics platform. Based on technology its founders developed and licensed from Harvard University: the Successive Proximity Extension Amplification Reaction (SPEAR), it allows the detection of single digit counts of protein molecules in tiny sample volumes, down to a tenth of a microliter. Whether measuring low abundance biomarkers with microsampling techniques or carrying out a multitude of tests on precious samples with limited volumes, it can become a solution for both research applications and minimally invasive diagnostics.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2021
- Website
- spear.bio/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of Spear Bio?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now